The Effect of Rituximab on the Development of Anti-Donor Antibodies and Resolution of B Cell Infiltration in the Renal Allograft of Patients Undergoing Rejection
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2014
At a glance
- Drugs Rituximab (Primary)
- Indications Kidney-pancreas transplant rejection; Renal transplant rejection
- Focus Therapeutic Use
- 06 Jul 2011 Actual end date Dec 2010 added as reported by ClinicalTrials.gov.
- 06 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jul 2008 New trial record.